HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Neuroprotection after ischemic stroke by activation of angiotensin receptor type 2: why clinical data do not fit the paradigm?

AuthorsEric Thorin, Giovanna Castoldi, Andrea Stella
JournalJournal of hypertension (J Hypertens) Vol. 33 Issue 1 Pg. 66-8 (Jan 2015) ISSN: 1473-5598 [Electronic] England
PMID25470121 (Publication Type: Editorial, Comment)
Chemical References
  • Angiogenesis Inducing Agents
  • Receptor, Angiotensin, Type 2
Topics
  • Angiogenesis Inducing Agents (chemistry)
  • Animals
  • Male
  • Neovascularization, Physiologic
  • Receptor, Angiotensin, Type 2 (metabolism)
  • Stroke (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: